Product Specific References | - Iggo R, Gatter K, Bartek J, Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. 1990. Lancet. 335:675-9. PMID: 1969059
- Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. 1990. EMBO J. 9:1595-602. PMID: 1691710
- Bartek J, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A, Kovarik J, Midgley CA, Gannon JV, Lane DP. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. 1991. Oncogene. 6:1699-703. PMID: 1923535
- Said JW, Barrera R, Shintaku IP, Nakamura H, Koeffler HP. Immunohistochemical analysis of p53 expression in malignant lymphomas. 1992. Am. J Pathol. 141:1343-8. PMID: 1466398
- Walker RA, Dearing SJ, Lane DP, Varley JM. Expression of p53 protein in infiltrating and in-situ breast carcinomas. 1991. J Pathol. 165:203-11. PMID: 1684809
|